NVS Novartis AG

-0.47 (-0.46%)
After Hours
Last Updated: 16:00:10
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Company Name Stock Ticker Symbol Market Type
Novartis AG NVS NYSE Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.47 -0.46% 101.86 16:00:10
Open Price Low Price High Price Close Price Prev Close
103.61 101.82 103.61 101.86 102.33
more quote information »

Recent News

Date Time Source Heading
9/29/202310:16IHNWFeaturedVolcon Announces First Shipment of Newly Updated Grunt EVO Electric Motorcycle Units
9/26/202302:03DJNNovartis's Sandoz to Commercialize Multiple Sclerosis..
9/25/202307:17IHMARKETNEWSMonday’s Wall Street Highlights: Ford, Amazon, Paramount,..
9/25/202302:08DJNNovartis's Radioligand Therapy Shows Survival Improvement..
9/19/202316:08EDGAR2Form 144 - Report of proposed sale of securities
9/18/202302:16DJNNovartis Cancer Drug Gets Marketing Recommendation from..
9/15/202309:32IHMARKETNEWSFriday’s Wall Street Highlights: Ford Motor, Arm,..
9/15/202306:27DJNNovartis Shareholders Give Green Light to Sandoz Spinoff
9/11/202310:00PRNUSNovartis Issues Voluntary Nationwide Recall of One Lot of..
9/11/202307:58DJNBausch + Lomb Launches Proposed Financing for Xiidra..
9/11/202302:02DJNNovartis's Sandoz to Commercialize Autoimmune Disorders..
9/05/202306:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/28/202309:05DJNNovartis's Leqvio Injection Effective at Reducing..
8/25/202308:50IHMARKETNEWSFriday’s Wall Street Highlights: Hawaiian Electric, Disney,..
8/25/202302:02DJNNovartis's Sandoz Gets FDA Approval for Multiple Sclerosis..
8/21/202306:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/18/202311:58DJNTrending: Novartis Set to Spin off Sandoz in October
8/18/202303:05DJNNovartis to Spin Off Sandoz in October -- Update
8/18/202302:14DJNNovartis Sets Sandoz Spinoff Date for Oct. 4
8/15/202302:11DJNNovartis Unit Sandoz Says Biosimilar Aflibercept Mylight..
8/09/202306:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/09/202302:11DJNNovartis's Remibrutinib Trials For Chronic Urticaria Meet..
7/18/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/18/202307:27IHMARKETNEWSTuesday’s Wall Street Highlights: Novartis, BofA, Dollar..
7/18/202302:00DJNNovartis Raises 2023 Guidance; Launches $15 Billion Buyback
7/17/202308:46DJNNovartis Buys DTx Pharma for $500 Million Plus Milestone..
7/17/202308:43DJNNovartis Buys DTx Pharma for $500 Million Plus Milestone..
7/17/202307:30IHMARKETNEWSMonday’s Wall Street Highlights: Microsoft, Santander,..
7/10/202316:08EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
7/10/202310:13DJNTrending: Novartis Gets FDA Approval for Expanded Use of..
7/10/202308:13DJNFDA Approves Expanded Use for Novartis' Leqvio
7/10/202306:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/10/202302:13DJNNovartis Backs 2023 Outlook Despite Court Red Light on Drug..
7/07/202307:51IHMARKETNEWSFriday’s Wall Street Highlights: Alibaba, Biogen, Uber,..
7/03/202301:47DJNNovartis's Sandoz Launches Arthritis Treatment in US
6/30/202311:50DJNBausch + Lomb Shares Climb After $2.5 Billion Deal to Buy..
6/12/202310:40DJNTrending: Novartis Buying Chinook Therapeutics for Up to..
6/12/202308:09DJNFlurry of European Companies Engaged in Acquisitions, Asset..
6/12/202301:53DJNNovartis to Acquire Chinook Therapeutics for Up to $3.5..
6/08/202302:03DJNNovartis's Sandoz Sets Out Growth Plan Following Proposed..
6/02/202308:49DJNNovartis Says Kisqali Significantly Lowered the Risk of..
6/01/202302:15DJNNovartis's Sandoz to Move to New Basel Headquarters After..
5/25/202302:00DJNNovartis's Sandoz Gets European Authorization for Biosimilar..
5/15/202302:08DJNNovartis Approves Sandoz's New Board Ahead of Spinoff
5/10/202304:33DJNEvotec Shares Jump After Sandoz Partnership Agreement
5/10/202302:07DJNNovartis Unit Sandoz Enters Partnership With Evotec..
4/26/202306:15DJNNovartis's Blood-Disorder Drug Trial Meets Primary Endpoint
4/25/202302:03DJNNovartis 1Q Profit, Sales Beat Expectations; Raises 2023..
3/27/202311:28DJNNovartis Up Over 7%, on Pace for Largest Percent Increase..
3/27/202303:57DJNNovartis Shares Gain After Positive Breast-Cancer Trial..
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now